Latest Articles
Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates - marketscreener.com
Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates marketscreener.com
Published: June 11, 2026, 1:52 p.m.
Medicus Pharma submits IND application for endometriosis trial By Investing.com - Investing.com Nigeria
Medicus Pharma submits IND application for endometriosis trial By Investing.com Investing.com Nigeria
Published: June 11, 2026, 11:58 a.m.
Medicus Pharma submits IND application for endometriosis trial - Investing.com
Medicus Pharma submits IND application for endometriosis trial Investing.com
Published: June 11, 2026, 11:55 a.m.
Medicus Pharma submits IND application for endometriosis trial By Investing.com - Investing.com Canada
Medicus Pharma submits IND application for endometriosis trial By Investing.com Investing.com Canada
Published: June 11, 2026, 11:41 a.m.
Medicus Pharma Ltd. Submits IND Application for Innovative PRECISION-E2 Phase 2a Clinical Trial in Endometriosis - Quiver Quantitative
Medicus Pharma Ltd. Submits IND Application for Innovative PRECISION-E2 Phase 2a Clinical Trial in Endometriosis Quiver Quantitative
Published: June 11, 2026, 11:41 a.m.
Applications open for the 2026 return of Ideas with Impact Awards - The National Tribune
Applications open for the 2026 return of Ideas with Impact Awards The National Tribune
Published: April 23, 2026, 12:02 p.m.
Endometriosis Drugs Sales Market Analysis By Application, - openPR.com
Endometriosis Drugs Sales Market Analysis By Application, openPR.com
Published: April 17, 2026, 11:10 a.m.
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
Biontech prepares FDA application after strong phase II results in endometrial cancer medwatch.com
Published: April 13, 2026, 12:14 p.m.
Applications open for Title X Family Planning Services Grants (US) - fundsforNGOs
Applications open for Title X Family Planning Services Grants (US) fundsforNGOs
Published: April 9, 2026, 7:38 a.m.
With a Record 70 Spots this Year, Team EndoStrong Has Opened Applications for the 2026 NYC Marathon - Endometriosis Foundation of America
With a Record 70 Spots this Year, Team EndoStrong Has Opened Applications for the 2026 NYC Marathon Endometriosis Foundation of America
Published: March 30, 2026, 7:45 p.m.
Link copied to clipboard!